Paroxetine HCL Controlled-Release Tablets 12.5 mg, 30-count bottle, Rx only, Manufactured by Glax...

FDA Drug Recall #D-1574-2014 — Class II — March 24, 2014

Recall Summary

Recall Number D-1574-2014
Classification Class II — Moderate risk
Date Initiated March 24, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Apotex Inc.
Location Toronto
Product Type Drugs

Product Description

Paroxetine HCL Controlled-Release Tablets 12.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3673-3

Reason for Recall

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Lot # 2A001, Exp. 01/15 Lot # 2A002, Exp. 01/15 Lot # 2C003, Exp. 03/15 Lot # 2F005, Exp. 06/15 Lot # 2G006, Exp. 07/15

Other Recalls from Apotex Inc.

Recall # Classification Product Date
D-1303-2020 Class II Metformin Hydrochloride Extended-Release Tablet... May 27, 2020
D-0153-2020 Class III Atorvastatin Calcium Tablets, USP 40 mg*, 1,000... Oct 22, 2019
D-0316-2020 Class II Equate Maximum Strength Ranitidine Tablets, USP... Sep 24, 2019
D-0317-2020 Class II Rite Aid Pharmacy Maximum Strength Ranitidine T... Sep 24, 2019
D-0318-2020 Class II Equate Maximum Strength Ranitidine Tablets, USP... Sep 24, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.